Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Boehringer Ingelheim Venture Fund
Brainomix secures £16M to expand AI-based platform for biomarker imaging
By
Anna Engberg
|
02:51 am |
December 23, 2021
After pioneering in stroke assessment, the investment will be directed to new therapeutic areas for lung fibrosis and cancer.
